Oregon Psilocybin Company Silo Wellness to Resume Trading on Canadian Securities Exchange Psychedelics Investing
Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock Medical Device Investing
Aptose to Participate in Canaccord Genuity's 2023 Horizons in Oncology Virtual Conference Market News
COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference Psychedelics Investing
Merck and Eisai Provide Update on Phase 3 Trials of KEYTRUDA® Plus LENVIMA® In Certain Patients With Advanced Melanoma and Metastatic Colorectal Cancer Life Science Investing
MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda , Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV Melanoma Following Complete Resection Life Science Investing
Silo Wellness Submits Annual Filings After Completion of Audited Financials; Management Commentary Psychedelics Investing
